veganism.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
Veganism Social is a welcoming space on the internet for vegans to connect and engage with the broader decentralized social media community.

Administered by:

Server stats:

299
active users

#patents

1 post1 participant0 posts today
PUPUWEB Blog<p><a href="https://mastodon.social/tags/Nokia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Nokia</span></a> and <a href="https://mastodon.social/tags/Amazon" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Amazon</span></a> settle their global patent dispute over Amazon using Nokia’s video tech in <a href="https://mastodon.social/tags/PrimeVideo" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PrimeVideo</span></a> &amp; devices. The terms remain undisclosed. A major shift in the tech patent landscape! <a href="https://mastodon.social/tags/TechNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>TechNews</span></a> <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Patents</span></a> <a href="https://mastodon.social/tags/VideoTech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>VideoTech</span></a> <a href="https://mastodon.social/tags/AmazonPrime" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AmazonPrime</span></a> <a href="https://mastodon.social/tags/Innovation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Innovation</span></a> <a href="https://mastodon.social/tags/LegalTech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LegalTech</span></a></p>
PUPUWEB Blog<p>US judge dismisses Samsung's Oura lawsuit, ruling Samsung acted prematurely in seeking judgment that Galaxy Ring doesn't infringe Oura's patents. ⚖️ <a href="https://mastodon.social/tags/Samsung" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Samsung</span></a> <a href="https://mastodon.social/tags/Oura" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Oura</span></a> <a href="https://mastodon.social/tags/Lawsuit" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Lawsuit</span></a> <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Patents</span></a> <a href="https://mastodon.social/tags/TechNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>TechNews</span></a> <a href="https://mastodon.social/tags/LegalNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LegalNews</span></a> <a href="https://mastodon.social/tags/GalaxyRing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GalaxyRing</span></a> <a href="https://mastodon.social/tags/IntellectualProperty" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>IntellectualProperty</span></a></p>
prabirkc<p><a href="https://www.himalmag.com/politics/india-pharma-regulation-drug-safety" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">himalmag.com/politics/india-ph</span><span class="invisible">arma-regulation-drug-safety</span></a> <a href="https://mastodon.social/tags/India" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>India</span></a> <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Patents</span></a> <a href="https://mastodon.social/tags/Pharmaceuticals" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Pharmaceuticals</span></a> <a href="https://mastodon.social/tags/Law" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Law</span></a></p>
prabirkc<p><a href="https://www.himalmag.com/politics/bangladesh-pharma-patents-safety-regulation" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">himalmag.com/politics/banglade</span><span class="invisible">sh-pharma-patents-safety-regulation</span></a> <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Patents</span></a> <a href="https://mastodon.social/tags/Pharmaceuticals" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Pharmaceuticals</span></a></p>
Newsramp<p>USPTO's proposed DOGE program may extend patent processing times, potentially disrupting innovation and intellectual property protections for businesses and inventors nationwide. Expect significant challenges ahead. <a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Patents</span></a> <a href="https://mastodon.social/tags/Innovation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Innovation</span></a></p>
Kevin Karhan :verified:<p><span class="h-card" translate="no"><a href="https://mstdn.jp/@landley" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>landley</span></a></span> <span class="h-card" translate="no"><a href="https://todon.nl/@burnoutqueen" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>burnoutqueen</span></a></span> Yeah...</p><p><a href="https://infosec.space/tags/GPLv3" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GPLv3</span></a> is a desaster as it's 99% ideology and 1% license text and alongside <a href="https://infosec.space/tags/AGPLv3" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AGPLv3</span></a> completely ignores the reality of how <a href="https://infosec.space/tags/licensing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>licensing</span></a> and <a href="https://infosec.space/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> and <a href="https://infosec.space/tags/IP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>IP</span></a> works.</p><ul><li>Not that I like the status-quo, but we'd rather see businesses steer clear of anything GPLv2+ or GPLv3 or worse.</li></ul><p>And on the flipside we basically get <em>"source available"</em> stuff like <a href="https://infosec.space/tags/SSPL" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SSPL</span></a> which only serves as a means to commit <a href="https://infosec.space/tags/AssetDenial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AssetDenial</span></a> and monopolize commercial offerings...</p><ul><li>I think <a href="https://infosec.space/tags/Linux" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Linux</span></a> being <a href="https://infosec.space/tags/GPLv2only" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GPLv2only</span></a> is a good compromise and my personal gripes with <a href="https://infosec.space/tags/FSF" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>FSF</span></a> &amp; <a href="https://infosec.space/tags/GNUtils" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GNUtils</span></a> as well as <a href="https://infosec.space/tags/GlibC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GlibC</span></a> are something different...</li></ul>
petersuber<p>Update. New study: "<a href="https://fediscience.org/tags/NIH" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NIH</span></a> investment in drugs approved from 2010 to 2019 was not less than investment by the <a href="https://fediscience.org/tags/pharmaceutical" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>pharmaceutical</span></a> industry, with comparable accounting for basic and applied research, failed clinical trials, and cost of capital or discount rates."<br><a href="https://jamanetwork.com/journals/jama-health-forum/fullarticle/2804378" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">jamanetwork.com/journals/jama-</span><span class="invisible">health-forum/fullarticle/2804378</span></a> </p><p>PS: Relevant to (1) <a href="https://fediscience.org/tags/Trump" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Trump</span></a> admin cutbacks to NIH <a href="https://fediscience.org/tags/funding" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>funding</span></a> and (2) industry <a href="https://fediscience.org/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> and licensing terms on approved drugs. </p><p><a href="https://fediscience.org/tags/Medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Medicine</span></a> <a href="https://fediscience.org/tags/Pharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Pharma</span></a></p>
GMWatch<p>New genetic engineering in farmed animals: critical review. Inadequate regulation of new <a href="https://mastodon.social/tags/GMO" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GMO</span></a> (NGT) animals will result in an increase in the number of animal experiments, animal losses and animal suffering; plus <a href="https://mastodon.social/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> on gene-edited need to be banned, warns Testbiotech. <a href="https://gmwatch.org/en/106-news/latest-news/20527" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">gmwatch.org/en/106-news/latest</span><span class="invisible">-news/20527</span></a></p>
IT News<p>The Effect of Application Fees on Entry into Patenting - The abstract of a paper published on National Bureau of Economic Research: Ensurin... - <a href="https://yro.slashdot.org/story/25/03/18/2047251/the-effect-of-application-fees-on-entry-into-patenting?utm_source=rss1.0mainlinkanon&amp;utm_medium=feed" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">yro.slashdot.org/story/25/03/1</span><span class="invisible">8/2047251/the-effect-of-application-fees-on-entry-into-patenting?utm_source=rss1.0mainlinkanon&amp;utm_medium=feed</span></a> <a href="https://schleuss.online/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a></p>
Europe Says<p><a href="https://www.europesays.com/1912964/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/1912964/</span><span class="invisible"></span></a> Why the UK Food Regulator is Trying to Legalize Lab-Grown Meat <a href="https://pubeurope.com/tags/biology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>biology</span></a> <a href="https://pubeurope.com/tags/diet" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>diet</span></a> <a href="https://pubeurope.com/tags/FARMING" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>FARMING</span></a> <a href="https://pubeurope.com/tags/Food" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Food</span></a> <a href="https://pubeurope.com/tags/GreatBritain" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>GreatBritain</span></a> <a href="https://pubeurope.com/tags/law" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>law</span></a> <a href="https://pubeurope.com/tags/NortheasternUniversityLondon" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NortheasternUniversityLondon</span></a> <a href="https://pubeurope.com/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedKingdom</span></a></p>
Dave Rahardja<p>I hope countries around the world feel emboldened to repeal all the intellectual property laws that they adopted in return for favorable terms of trade with the US. None of it matters any more. It should be apparent now that US tariffs are getting applied RANDOMLY, to countries EVEN WHEN THEY COMPLY WITH ALL TRADE DEALS. I hope they do themselves a favor and free their societies from the shackles of US economic imperialism and innovate in a way that US companies cannot.</p><p><a href="https://sfba.social/tags/intellectualProperty" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>intellectualProperty</span></a> <a href="https://sfba.social/tags/copyright" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>copyright</span></a> <a href="https://sfba.social/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> <a href="https://sfba.social/tags/tariffs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>tariffs</span></a></p>
Dustin<p>At least now the possibility of the Apple Watch ECG function being turned off is gone.</p><p>I wonder if Apple Watches will ever again have blood oxygen running on them? This is actually one reason I don't want to upgrade mine as it was purchased before this ban and still has this functionality.</p><p><a href="https://mastodon.social/tags/Apple" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Apple</span></a><br><a href="https://mastodon.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Patents</span></a><br><a href="https://mastodon.social/@macrumors/114123001817152544" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">mastodon.social/@macrumors/114</span><span class="invisible">123001817152544</span></a></p>
Otis Scops aka Crash Course<p>I always love a good initiative that circumvents or limits big-techs' horrible monopolism and arrogance and abuse of patents, copy-rights and whatever laws and rules that are never there to protect YOU, but always to protect capital!</p><p>So...</p><p>Get honest answers to the questions that have been bugging you about technology. And get to know how the Electronic Frontier Foundation (EFF) fights every day to make sure your rights follow you into the digital world.<br>Ever wondered...</p><p> Why is it so expensive to repair my devices?<br> Can the government read my text messages?<br> Is my phone listening to me?<br> Do I really own the digital media I bought?<br> Why is printer ink so expensive?</p><p><a href="https://www.digitalrightsbytes.org/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">digitalrightsbytes.org/</span><span class="invisible"></span></a></p><p><a href="https://kolektiva.social/tags/capitalism" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>capitalism</span></a> <a href="https://kolektiva.social/tags/monopoly" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>monopoly</span></a> technology <a href="https://kolektiva.social/tags/BigTech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BigTech</span></a> <a href="https://kolektiva.social/tags/copyright" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>copyright</span></a> <a href="https://kolektiva.social/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> <a href="https://kolektiva.social/tags/CrashCourse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CrashCourse</span></a></p>
Typographica<p>Fun type design and labor facts:</p><p>1. The first US design patent was a typeface patent.<br><a href="https://typographica.org/on-typography/copyright-protection-of-typefaces/#comment-1418735" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">typographica.org/on-typography</span><span class="invisible">/copyright-protection-of-typefaces/#comment-1418735</span></a></p><p>The US denies copyright protection for typefaces, but not font software (for now… <a href="https://typedrawers.com/discussion/comment/65603/#Comment_65603" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">typedrawers.com/discussion/com</span><span class="invisible">ment/65603/#Comment_65603</span></a>). </p><p>Foundries may be able to protect a type design with a patent, and a typeface name with a trademark. <br><a href="https://www.commarts.com/columns/fonts-and-the-law" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">commarts.com/columns/fonts-and</span><span class="invisible">-the-law</span></a></p><p><a href="https://typo.social/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Patents</span></a> <a href="https://typo.social/tags/Copyright" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Copyright</span></a> <a href="https://typo.social/tags/Fonts" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Fonts</span></a> <a href="https://typo.social/tags/TypeDesign" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>TypeDesign</span></a> <a href="https://typo.social/tags/Typefaces" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Typefaces</span></a> <a href="https://typo.social/tags/Typography" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Typography</span></a> <a href="https://typo.social/tags/TrademarkLaw" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>TrademarkLaw</span></a> <a href="https://typo.social/tags/Labor" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Labor</span></a> <a href="https://typo.social/tags/Unions" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Unions</span></a> <a href="https://typo.social/tags/Typography" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Typography</span></a> <a href="https://typo.social/tags/TypeDesign" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>TypeDesign</span></a> <a href="https://typo.social/tags/Printing" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Printing</span></a> <a href="https://typo.social/tags/WomensHistoryMonth" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>WomensHistoryMonth</span></a></p>
Maria Chiara Pievatolo<p>" Now that <a href="https://poliversity.it/tags/Trump" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Trump</span></a> has announced that the terms of US free trade deals are optional (for the US, at least), there's no reason not to <strong>delete Article 6 of the <a href="https://poliversity.it/tags/EUCD" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EUCD</span></a>, and all the other laws that prevent European companies from jailbreaking</strong> iPhones and making their own App Stores (minus Apple's 30% commission), as well as ad-blockers for Facebook and Instagram's apps (which would zero out EU revenue for Meta), and, of course, jailbreaking tools for Xboxes, Teslas, and every make and model of every American car, <strong>so European companies could offer service, parts, apps, and add-ons for them</strong>."</p><p><a href="https://pluralistic.net/2025/03/04/object-permanence/#picks-and-shovels" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">pluralistic.net/2025/03/04/obj</span><span class="invisible">ect-permanence/#picks-and-shovels</span></a></p><p>If European politicians were not vassals under the heel of the same masters, this could be a more powerful and fairer response than buying (patented) US weapons.</p><p>But the <a href="https://poliversity.it/tags/EU" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EU</span></a> defended <a href="https://poliversity.it/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> even on vaccines in the middle of a deadly pandemic. They chose death over freedom and are planning to do it again.</p>
The Japan Times<p>The Supreme Court has rejected FC2's appeals against two lower court rulings ordering the Las Vegas-based video-sharing platform operator to stop violating Japanese peer Dwango's patent on a comment-posting system. <a href="https://www.japantimes.co.jp/news/2025/03/04/japan/crime-legal/dwango-fc2-top-court/?utm_medium=Social&amp;utm_source=mastodon" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">japantimes.co.jp/news/2025/03/</span><span class="invisible">04/japan/crime-legal/dwango-fc2-top-court/?utm_medium=Social&amp;utm_source=mastodon</span></a> <a href="https://mastodon.social/tags/japan" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>japan</span></a> <a href="https://mastodon.social/tags/crimelegal" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>crimelegal</span></a> <a href="https://mastodon.social/tags/fc2" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>fc2</span></a> <a href="https://mastodon.social/tags/dwango" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>dwango</span></a> <a href="https://mastodon.social/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> <a href="https://mastodon.social/tags/supremecourt" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>supremecourt</span></a> <a href="https://mastodon.social/tags/internet" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>internet</span></a></p>
Emeritus Prof Christopher May<p>This week I've been mainly reading, no. 214. </p><p>Nicola Griffith's novel of corporate control of intellectual property &amp; the owners' family intrigues is sort of sci-fi, but really Slow River (1995/2012) is a business thriller (both legitimate &amp; illegitimate businesses). Its a well written &amp; intriguing read, which has a number of reveals that work well. To the extent is steps between genres its difficult to place, but very much worth reading.</p><p><span class="h-card" translate="no"><a href="https://a.gup.pe/u/bookstodon" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>bookstodon</span></a></span> <a href="https://zirk.us/tags/books" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>books</span></a> <a href="https://zirk.us/tags/business" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>business</span></a> <a href="https://zirk.us/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> <a href="https://zirk.us/tags/scifi" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>scifi</span></a></p>
Alexander J. Stein<p><a href="https://mastodon.world/tags/Patent" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Patent</span></a> publications by European alternative <a href="https://mastodon.world/tags/protein" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>protein</span></a> innovators increased by 960% since 2015, but important areas (e.g. <a href="https://mastodon.world/tags/plantbreeding" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>plantbreeding</span></a> of better protein crops to provide raw ingredients for <a href="https://mastodon.world/tags/plantbased" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>plantbased</span></a> products) remain neglected. Few <a href="https://mastodon.world/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> are published on cultivated <a href="https://mastodon.world/tags/meat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>meat</span></a> &amp; precision <a href="https://mastodon.world/tags/fermentation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>fermentation</span></a>, and just 1% of patents relates to alternative <a href="https://mastodon.world/tags/seafood" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>seafood</span></a>, highlighting need for more research: <a href="https://gfieurope.org/blog/report-european-alternative-protein-patents-jump-by-960-in-10-years/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">gfieurope.org/blog/report-euro</span><span class="invisible">pean-alternative-protein-patents-jump-by-960-in-10-years/</span></a> <a href="https://mastodon.world/tags/innovation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>innovation</span></a> <a href="https://mastodon.world/tags/research" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>research</span></a> <a href="https://mastodon.world/tags/cleanmeat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>cleanmeat</span></a> <a href="https://mastodon.world/tags/cultivatedmeat" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>cultivatedmeat</span></a> <a href="https://mastodon.world/tags/precisionfermentation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>precisionfermentation</span></a></p>
Karsten Schmidt<p>Some people are dedicating their entire adult life to sharing ideas, knowledge and inspiration with others in the hope to bring forth a better world, others are dedicating their years to hoarding patents for every little "insight" (incl. brain farts) they ever had or been involved with, and then use this collection of accumulated "IP" as central/singular thesis to brag about on their website...</p><p>Case in point, the personal website of Humane AI's CEO:<br><a href="http://www.imranchaudhri.com/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">http://www.</span><span class="">imranchaudhri.com/</span><span class="invisible"></span></a></p><p>🤯</p><p><a href="https://mastodon.thi.ng/tags/Patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Patents</span></a></p>
Europe Says<p><a href="https://www.europesays.com/1843351/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">europesays.com/1843351/</span><span class="invisible"></span></a> EC Withdraws Draft Rules on Patents, AI Liability, Privacy <a href="https://pubeurope.com/tags/AI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AI</span></a> <a href="https://pubeurope.com/tags/ArtificialIntelligence" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ArtificialIntelligence</span></a> <a href="https://pubeurope.com/tags/eu" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>eu</span></a> <a href="https://pubeurope.com/tags/europe" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>europe</span></a> <a href="https://pubeurope.com/tags/EuropeanCommission" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EuropeanCommission</span></a> <a href="https://pubeurope.com/tags/EuropeanUnion" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EuropeanUnion</span></a> <a href="https://pubeurope.com/tags/MessagingApps" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MessagingApps</span></a> <a href="https://pubeurope.com/tags/News" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>News</span></a> <a href="https://pubeurope.com/tags/patents" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patents</span></a> <a href="https://pubeurope.com/tags/privacy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>privacy</span></a> <a href="https://pubeurope.com/tags/PYMNTSNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PYMNTSNews</span></a> <a href="https://pubeurope.com/tags/regulation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>regulation</span></a> <a href="https://pubeurope.com/tags/What" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>What</span></a>'sHot</p>